Chronic hepatitis C is associated with peripheral rather than hepatic insulin resistance. - Wikidata - wikimedia - TriplyDB

Chronic hepatitis C is associated with peripheral rather than hepatic insulin resistance.

Chronic hepatitis C is associated with peripheral rather than hepatic insulin resistance.

http://www.wikidata.org/entity/Q35016133

about

Morphologic features of extrahepatic manifestations of hepatitis C virus infection Hepatitis C Virus, Insulin Resistance, and Steatosis Type 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection--Liver: The "Musketeer" in the Spotlight Hepatitis C and insulin action: An intimate relationship Pathophysiology of insulin resistance and steatosis in patients with chronic viral hepatitis Hepatitis C virus and metabolic disorder interactions towards liver damage and atherosclerosis.Muscle Sympathetic Nerve Activity Is Associated with Liver Insulin Sensitivity in Obese Non-Diabetic Men.Metabolic syndrome in chronic hepatitis C infection: does it still matter in the era of directly acting antiviral therapy?Individualisation of antiviral therapy for chronic hepatitis C.Liver inflammation is a risk factor for prediabetes in at-risk latinos with and without hepatitis C infection.Changes in circulating lipids level over time after acquiring HCV infection: results from ERCHIVES.Conversion from Tacrolimus to Cyclosporine A Improves Glucose Tolerance in HCV-Positive Renal Transplant Recipients.Impact of insulin resistance on HCV treatment response and impact of HCV treatment on insulin sensitivity using direct measurements of insulin action A Taiwanese Nationwide Cohort Study Shows Interferon-Based Therapy for Chronic Hepatitis C Reduces the Risk of Chronic Kidney Disease Insulin sensitivity and variability in hepatitis C virus infection using direct measurement Current level of evidence on causal association between hepatitis C virus and type 2 diabetes: A review.Interaction between hepatitis C virus and metabolic factors.Organelle dysfunction in hepatitis C virus-associated steatosis: anything to learn from nonalcoholic steatohepatitis?Hepatitis C virus-associated insulin resistance: pathogenic mechanisms and clinical implications.Current understanding of insulin resistance in hepatitis C.Use of HOMA-IR in hepatitis C.Diabetes mellitus following liver transplantation in patients with hepatitis C virus: risks and consequences.Steatosis and insulin resistance in response to treatment of chronic hepatitis C.The burden of diabetes and hyperlipidemia in treated HIV infection and approaches for cardiometabolic care.Hepatitis C virus diversity and hepatic steatosis.Role of inflammation in HIV-1 disease progression and prognosis.Hepatitis C virus infection and kidney transplantation in 2014: what's new?Peroxisome proliferator-activated receptors and hepatitis C virus Hepatitis C Virus Infection in Chronic Kidney Disease.Hepatogenous diabetes: Is it time to separate it from type 2 diabetes?Opportunities for treatment of the hepatitis C virus-infected patient with chronic kidney disease.Effects of hepatitis C virus on suppressor of cytokine signaling mRNA levels: comparison between different genotypes and core protein sequence analysis.HCV-infected Renal Transplant Recipients: Our Experience before the Availability of New Antiviral Drugs.Successful Withdrawal of Insulin Therapy After Post-Treatment Clearance of Hepatitis C Virus in a Man with Type 2 Diabetes.Transplantation of kidneys from hepatitis C-positive donors into hepatitis C virus-infected recipients followed by early initiation of direct acting antiviral therapy: a single-center retrospective study.The Impact of Prior Flavivirus Infections on the Development of Type 2 Diabetes Among the Indigenous Australians.Successful Hepatitis C Antiviral Therapy Induces Remission of Type 2 Diabetes: A Case Report.Eradicating hepatitis C virus ameliorates insulin resistance without change in adipose depots.IRS1 Expression in Hepatic Tissue and Leukocytes in Chronic Hepatitis C Virus Infected Patients: A Comparative Study Homeostasis model assessment of insulin resistance does not seem to predict response to telaprevir in chronic hepatitis C in the REALIZE trial.

P2860

Q21284981-0AF5C98E-E306-4635-86FD-CEBB06F761F2 Q26751755-245B54A6-A950-42EA-8CF9-9E1599417BF2 Q26752583-FFD634DE-DD51-4FC2-83B2-8120E1C81C51 Q26775000-F8F98F3D-A01A-4921-8CC9-00BDFC5DB333 Q27022707-9151EC2E-BC3B-4E7A-9064-9BDE24535225 Q30360538-414C06B8-B5BE-4E4E-88BE-80731C060C87 Q30361143-2BB692BF-4CA8-447A-9404-F9E669C799B7 Q30369757-215FCA1B-AB3B-4FBB-B891-D0D1B6F9B544 Q33390478-1287CDF3-EFC6-4C86-96C6-37197FBCF0FC Q34943906-4AE13780-CE70-4DD4-8832-F8B6BF41C744 Q35838417-BB0B13BD-CE22-42CA-853F-549924FB8531 Q35886733-8E0C1455-22F9-4A46-A5E1-0E65994FCF11 Q35898216-64191246-99C6-4970-88EB-783395D47F94 Q36195230-ACC3A170-20D9-4816-8F67-8D79B5356C3B Q36592257-E7270AE6-6E2F-4428-A597-2A75889A7B4B Q37610878-B1173C39-817E-442C-B717-D3A6BD0C9932 Q37654443-71191493-0036-46E3-B962-070BB034F273 Q37863141-1F0E9F21-B678-45BC-8649-58FEBCD5EDE0 Q37879191-CC9791A6-3890-4331-870B-CCAEB6C63C01 Q37903853-528A6FEE-3AC2-43BF-AE2C-66A47996E688 Q37931383-0057829A-0175-49F1-AFCE-D8A6C3C9674C Q37962197-578A2398-5AEF-43E6-B0EA-11E3A1D44938 Q37974700-77E89127-C915-4BDA-9320-4F2A4C6EF630 Q38023235-358861CD-BB2C-4817-B23A-9482D98CC06D Q38072721-73AEC6AB-0634-4DFA-91BF-9AC728B3B039 Q38183454-C81112FE-670D-48AC-BDD8-56E70BC2DD5D Q38236820-D48CB03F-579E-4C18-ACDD-C5D01BE8B93F Q38633502-A95CD08C-2C7C-408B-9E96-A34E6DB0B595 Q38812607-5BB9EEF1-C452-4A0A-8632-E88DCFE29889 Q39036315-7D3AE1B4-E062-45E6-9D08-6AC7C9F63D3A Q39455853-4DE39B58-DE80-4387-96DF-37F212222CF3 Q39556422-B25A5441-44F1-4DFF-8C1F-02992AEED27D Q40084859-0118AEFD-A753-44E9-9930-9D6684C56E1A Q40240819-B95E3B3E-0F3E-4999-9D1B-175A6567EFB4 Q40278746-A94F0665-71F3-46FA-92F6-CA0E92267A7E Q40361262-2A1A996F-EF5C-4AEF-88E7-16314023F207 Q40945393-C9F0B8ED-105C-4540-BDF7-B51B2AD8CC9E Q42225921-9F61AFB4-6334-455E-939A-6CFAE3CA86CC Q42239659-4337D70D-6FAF-46C1-A584-DD56CC3B9F2C Q42245782-790C87DE-1989-429C-A779-F46F0FE8A143

P2860

Chronic hepatitis C is associated with peripheral rather than hepatic insulin resistance.

http://www.wikidata.org/entity/Q35016133

description

2009 nî lūn-bûn

@nan

2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Chronic hepatitis C is associated with peripheral rather than hepatic insulin resistance.

@ast

Chronic hepatitis C is associated with peripheral rather than hepatic insulin resistance.

@en

type

label

Chronic hepatitis C is associated with peripheral rather than hepatic insulin resistance.

@ast

Chronic hepatitis C is associated with peripheral rather than hepatic insulin resistance.

@en

prefLabel

Chronic hepatitis C is associated with peripheral rather than hepatic insulin resistance.

@ast

Chronic hepatitis C is associated with peripheral rather than hepatic insulin resistance.

@en

P1433

Q35016133-2639F25E-6716-4B3E-A183-747A4DF2FAF4

P1476

Q35016133-0D6E1EAC-8B88-4A88-B30F-C0F6F1744709

P2093

Q35016133-095E1737-FFC2-4B44-B43D-43FE592C6CF8

Q35016133-165FE2A2-FAB9-4A37-BEA3-D13E98FA3805

Q35016133-22E9154F-374D-4522-A5D3-901CC87F00E3

Q35016133-4C99D7B8-1DC5-431A-9379-9457DA9B47A8

Q35016133-72129E34-6C49-44DC-8A0C-E90ADE90FF61

Q35016133-8EC6D6DD-FC37-4C1B-874B-69489CAA8089

Q35016133-9291BC46-68DC-43D8-9EAF-0C89F93E06DE

Q35016133-94A2ED6E-434A-4E0C-9DD0-B196AAA4067D

Q35016133-BD66436F-FFA9-459D-83C0-F86DB571657B

P304

Q35016133-FB5F8795-6E19-45BA-B962-DD89B8782CE6

P31

Q35016133-0B9FA6A8-D792-447B-B178-F1936465A829

P356

Q35016133-1CEEB6C4-9C56-4212-A076-7606F71FBD03

P407

Q35016133-37CCC7E5-17DD-4FD6-B61D-B044D2F53269

P433

Q35016133-5B81D508-A513-4A04-90BD-512C337B747A

P478

Q35016133-F96207CB-315A-491B-9858-2041C5F5B116

P50

Q35016133-10555ADD-C118-4A9B-86E3-BFF0C80617B4

Q35016133-60C11B7B-E15A-4FC9-AEA1-92735F05CBAC

Q35016133-CD185DFF-89BB-4121-A19F-E5F5AD552517

P577

Q35016133-4900DC62-CDC6-48AB-84EC-9DACEDC50B13

P698

Q35016133-E557F38F-F120-4802-86F4-AF71D7F042F9

P921

Q35016133-3977217D-68B0-45EF-9061-8A484023361A

P356

J.GASTRO.2009.11.050

P1433

Gastroenterology

P1476

Chronic hepatitis C is associated with peripheral rather than hepatic insulin resistance

@en

P2093

Aimin Xu

http://www.w3.org/2001/XMLSchema#string

David van der Poorten

http://www.w3.org/2001/XMLSchema#string

Donald J Chisholm

http://www.w3.org/2001/XMLSchema#string

George Smythe

http://www.w3.org/2001/XMLSchema#string

Gregory J Dore

http://www.w3.org/2001/XMLSchema#string

Jacob George

http://www.w3.org/2001/XMLSchema#string

Kerry-Lee Milner

http://www.w3.org/2001/XMLSchema#string

Martin Weltman

http://www.w3.org/2001/XMLSchema#string

Vincent Fragomeli

http://www.w3.org/2001/XMLSchema#string

P304

932-41.e1-3

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/J.GASTRO.2009.11.050

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

138

http://www.w3.org/2001/XMLSchema#string

P50

Michael I Trenell

Arthur B Jenkins

P577

2009-12-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19962985

http://www.w3.org/2001/XMLSchema#string

P921